ProKidney (PROK) Fundamental Analysis: Revenue, Earnings & Valuation

5.39 / 10

Netural

Fundamental analysis rates PROK neutral at 5.4/10. Revenue‑MV and Cash‑MV are strengths, but Fixed‑assets turnover and PB‑ROE lag, pulling the score down. Overall the company appears fairly valued with selective upside potential.

Analysis Checks(8/10)

Revenue-MV

Value-6.10

Score2/3

Weight17.35%

1M Return8.45%

Total operating revenue (YoY growth rate %)

Value1075.00

Score3/3

Weight2.75%

1M Return1.54%

Inventory turnover ratio

Value103.94

Score3/3

Weight14.14%

1M Return6.74%

Gross profit margin (%)

Value100.00

Score2/3

Weight3.22%

1M Return1.69%

PB-ROE

Value0.89

Score1/3

Weight11.85%

1M Return5.29%

Income tax / Total profit (%)

Value-0.27

Score2/3

Weight1.89%

1M Return1.04%

Fixed assets turnover ratio

Value0.02

Score1/3

Weight-1.97%

1M Return-1.24%

Cost of sales ratio (%)

Value64.41

Score3/3

Weight8.18%

1M Return4.32%

Asset-MV

Value-0.55

Score3/3

Weight30.02%

1M Return11.84%

Cash-MV

Value0.02

Score2/3

Weight12.56%

1M Return5.94%

Is PROK undervalued or overvalued?

PROK scores 5.39/10 on fundamentals and holds a Fair valuation at present. Backed by its -19.64% ROE, -16977.83% net margin, -8.32 P/E ratio, 1.91 P/B ratio, and 16.13% earnings growth, these metrics solidify its Netural investment rating.